TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin.
Authors
Jones, RCrabb, S
Chester, J
Elliott, Tony
Huddart, R
Birtle, A
Evans, L
Lester, J
Huang, C
Casbard, A
Madden, T
Griffiths, G
Griffiths, G
Affiliation
University of Glasgow, Beatson West of Scotland Cancer Centre, GlasgowIssue Date
2016